Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0VP1V
|
|||
| Former ID |
DNCL002793
|
|||
| Drug Name |
Aclidinium
|
|||
| Synonyms |
Aclidinium; UNII-K17VY42F6C; K17VY42F6C; CHEBI:65346; 727649-81-2; CHEMBL551466; (3R)-3-[2-hydroxy(di-2-thienyl)acetoxy]-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane; (3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide; SCHEMBL72141; GTPL7449; SCHEMBL15096073; CHEMBL1194325; DTXSID00223070; ZINC30691727; BDBM50296331; DB08897; AJ-84146; AB01565828_02; 1-(3-Phenoxypropyl)-3alpha-[hydroxybis(2-thienyl)acetyloxy]-1-azoniabicyclo[2.2.2]octane
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Chronic obstructive pulmonary disease [ICD-11: CA22; ICD-10: J44, J44.9] | Approved | [1], [2] | |
| Company |
Almirall
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C26H30NO4S2+
|
|||
| Canonical SMILES |
C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5
|
|||
| InChI |
1S/C26H30NO4S2/c28-25(26(29,23-9-4-17-32-23)24-10-5-18-33-24)31-22-19-27(14-11-20(22)12-15-27)13-6-16-30-21-7-2-1-3-8-21/h1-5,7-10,17-18,20,22,29H,6,11-16,19H2/q+1/t20?,22-,27?/m0/s1
|
|||
| InChIKey |
ASMXXROZKSBQIH-VITNCHFBSA-N
|
|||
| CAS Number |
CAS 727649-81-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| ChEBI ID |
CHEBI:65346
|
|||
| ADReCS Drug ID | BADD_D02465 | |||
| SuperDrug ATC ID |
R03BB05
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7449). | |||
| REF 2 | Duaklir Genuair approved in the European Union for chronic obstructive pulmonary disease | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.